Status and phase
Conditions
Treatments
About
Intracoronary bolus Abciximab single is non-inferior to intravenous and continuous 12- hours infusion in the size reduction of infarction on cardiac magnetic resonance in Non-ST elevation Myocardial infarction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Loading...
Central trial contact
Myung-Ki Seo, MD; Hyun-Jae Kang, Prof
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal